These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9020687)

  • 21. The second-trimester fetal iliac angle as a sign of Down's syndrome.
    Shipp TD; Bromley B; Lieberman E; Benacerraf BR
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):15-8. PubMed ID: 9697278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface anatomy of the face in Down's syndrome: linear and angular measurements in the craniofacial regions.
    Farkas LG; Katic MJ; Forrest CR; Litsas L
    J Craniofac Surg; 2001 Jul; 12(4):373-9; discussion 380. PubMed ID: 11482623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex.
    Bajo M; Fruehauf J; Kim SH; Fountoulakis M; Lubec G
    Proteomics; 2002 Nov; 2(11):1539-46. PubMed ID: 12442254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal genetic services for Down's syndrome: access and provision in 1990-1991. Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
    Williamson P; Harris R; Church S; Fiddler M; Rhind J
    Br J Obstet Gynaecol; 1996 Jul; 103(7):676-83. PubMed ID: 8688395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative study of the face in Down's syndrome.
    Fink GB; Madaus WK; Walker GF
    Am J Orthod; 1975 May; 67(5):540-53. PubMed ID: 123708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Craniofacial manifestations of virus-induced mongolism in the hamster and Down's syndrome in man.
    Baer PN; Coccaro PJ; Baer MJ; Kilham L
    Am J Orthod; 1971 Sep; 60(3):221-34. PubMed ID: 4254969
    [No Abstract]   [Full Text] [Related]  

  • 28. Biparietal diameter/femur length ratio and actual femur length/expected femur length ratio: a sonographic screening method for Down's syndrome.
    Sukcharoen N; Tannirandorn Y; Suwajanakorn S; Paosawadi S
    J Med Assoc Thai; 1992 Aug; 75(8):483-7. PubMed ID: 1300366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between differences in regional growth rates and changes in shape during human fetal craniofacial growth.
    Trenouth MJ
    Arch Oral Biol; 1985; 30(1):31-5. PubMed ID: 3857883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incorporation of maternal age into the sonographic scoring index for the detection at 14-20 weeks of fetuses with Down's syndrome.
    Bromley B; Lieberman E; Benacerraf BR
    Ultrasound Obstet Gynecol; 1997 Nov; 10(5):321-4. PubMed ID: 9444045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chick embryo as a model for the effects of prenatal exposure to alcohol on craniofacial development.
    Kiecker C
    Dev Biol; 2016 Jul; 415(2):314-325. PubMed ID: 26777098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biometry of face and brain in fetuses with trisomy 21.
    Guihard-Costa AM; Khung S; Delbecque K; Ménez F; Delezoide AL
    Pediatr Res; 2006 Jan; 59(1):33-8. PubMed ID: 16326987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Echographic measuring of the length of the fetal femur in the screening for Down syndrome].
    Biagiotti R; Periti E; Cariati E; Nannini R
    Minerva Ginecol; 1992 Dec; 44(12):609-12. PubMed ID: 1491768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of human craniofacial morphology during the late embryonic and early fetal periods.
    Diewert VM
    Am J Orthod; 1985 Jul; 88(1):64-76. PubMed ID: 3860013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative evaluation of craniofacial growth in the third trimester human.
    Plavcan JM; German RZ
    Cleft Palate Craniofac J; 1995 Sep; 32(5):394-404. PubMed ID: 7578204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in the relative amounts of specific mRNA species in the developing human brain in Down's syndrome.
    Whatley SA; Hall C; Davison AN; Lim L
    Biochem J; 1984 May; 220(1):179-87. PubMed ID: 6204644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alphafetoprotein in midtrimester Down's syndrome fetal serum.
    Seller MJ
    J Med Genet; 1990 Apr; 27(4):240-3. PubMed ID: 1691297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sonographic identification of second-trimester fetuses with Down's syndrome.
    Benacerraf BR; Gelman R; Frigoletto FD
    N Engl J Med; 1987 Nov; 317(22):1371-6. PubMed ID: 2960895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.